IRIDEX Corporation (IRIX)

NASDAQ: IRIX · Real-Time Price · USD
0.9991
+0.1161 (13.15%)
At close: Mar 28, 2025, 4:00 PM
0.9521
-0.0470 (-4.70%)
After-hours: Mar 28, 2025, 7:48 PM EDT
13.15%
Market Cap 16.62M
Revenue (ttm) 48.67M
Net Income (ttm) -8.91M
Shares Out 16.64M
EPS (ttm) -0.54
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 449,503
Open 1.0600
Previous Close 0.8830
Day's Range 0.9101 - 1.0650
52-Week Range 0.7800 - 3.6500
Beta 0.94
Analysts Hold
Price Target 2.00 (+100.18%)
Earnings Date Mar 27, 2025

About IRIX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retino... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Feb 15, 1996
Employees 111
Stock Exchange NASDAQ
Ticker Symbol IRIX
Full Company Profile

Financial Performance

In 2024, IRIDEX's revenue was $48.67 million, a decrease of -6.17% compared to the previous year's $51.87 million. Losses were -$8.91 million, -6.90% less than in 2023.

Financial Statements

Analyst Forecast

According to one analyst, the rating for IRIX stock is "Hold" and the 12-month stock price forecast is $2.0.

Price Target
$2.0
(100.18% upside)
Analyst Consensus: Hold
Stock Forecasts

News

IRIDEX Corporation (IRIX) Q4 2024 Earnings Call Transcript

IRIDEX Corporation (NASDAQ:IRIX) Q4 2024 Earnings Conference Call March 27, 2025 5:00 PM ET Company Participants Trip Taylor - Investor Relations Department Patrick Mercer - Chief Executive Officer R...

2 days ago - Seeking Alpha

Iridex Reports Fourth Quarter and Full Year 2024 Financial Results

MOUNTAIN VIEW, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pr...

2 days ago - GlobeNewsWire

Iridex Announces Strategic Investment in the Company

MOUNTAIN VIEW, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for ...

11 days ago - GlobeNewsWire

Iridex Comments on Recent Stock Price Volatility

MOUNTAIN VIEW, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for ...

16 days ago - GlobeNewsWire

Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

MOUNTAIN VIEW, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for ...

16 days ago - GlobeNewsWire

Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management

MOUNTAIN VIEW, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for t...

3 months ago - GlobeNewsWire

Iridex Comments on Changing Glaucoma Reimbursement Landscape

MOUNTAIN VIEW, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pro...

4 months ago - GlobeNewsWire

IRIDEX Corporation (IRIX) Q3 2024 Earnings Call Transcript

IRIDEX Corporation (NASDAQ:IRIX) Q3 2024 Earnings Call Transcript November 12, 2024 5:00 PM ET Company Participants Scott Shuda - Executive Chairman Patrick Mercer - CEO Fuad Ahmad - Interim CFO Oper...

4 months ago - Seeking Alpha

Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024

MOUNTAIN VIEW, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pro...

5 months ago - GlobeNewsWire

Iridex Appoints Patrick Mercer as Chief Executive Officer

MOUNTAIN VIEW, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pro...

6 months ago - GlobeNewsWire

Iridex Frustrates, But Expect A Transaction By Year-End

IRIDEX has faced delays in selling its assets as part of a strategic review initiated a year ago, causing frustration among shareholders. Despite setbacks, the company remains committed to selling all...

7 months ago - Seeking Alpha

IRIDEX Corporation (IRIX) Q2 2024 Earnings Call Transcript

IRIDEX Corporation (NASDAQ:IRIX) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Philip Taylor – Investor Relations David Bruce – Chief Executive Officer Fuad Ahmad – ...

8 months ago - Seeking Alpha

IRIDEX Corporation (IRIX) Q1 2024 Earnings Call Transcript

IRIDEX Corporation (NASDAQ:IRIX) Q1 2024 Earnings Conference Call May 14, 2024 5:00 PM ET Company Participants Trip Taylor - Investor Relations David Bruce - Chief Executive Officer Fuad Ahmad - Inte...

11 months ago - Seeking Alpha

Iridex Reports First Quarter 2024 Financial Results

MOUNTAIN VIEW, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and proc...

11 months ago - GlobeNewsWire

Iridex's Strategic Review Process Should Bear Fruit 'Soon'

Iridex Corporation is undergoing a strategic review process to unlock shareholder value. The company is likely to sell its retina business line and potentially parse it out in more than one transactio...

1 year ago - Seeking Alpha

IRIDEX Corporation (IRIX) Q4 2023 Earnings Call Transcript

IRIDEX Corporation (IRIX) Q4 2023 Earnings Call Transcript

1 year ago - Seeking Alpha

Iridex Reports Fourth Quarter and Full Year 2023 Financial Results

MOUNTAIN VIEW, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pr...

1 year ago - GlobeNewsWire

Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024

MOUNTAIN VIEW, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pr...

1 year ago - GlobeNewsWire

Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust

MOUNTAIN VIEW, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation, headquartered in Mountain View, California, and Imperial College Healthcare NHS Trust in London, today announced the first ...

1 year ago - GlobeNewsWire

Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma

MOUNTAIN VIEW, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation, a global leader in innovative laser-based medical systems for the treatment of eye diseases, proudly announces the US launc...

1 year ago - GlobeNewsWire

Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation

Action Retains Full Patient Access to MicroPulse® Transscleral Laser Treatment Action Retains Full Patient Access to MicroPulse® Transscleral Laser Treatment

1 year ago - GlobeNewsWire

Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation

MOUNTAIN VIEW, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pro...

1 year ago - GlobeNewsWire

Iridex Reports Third Quarter 2023 Financial Results and Business Update

MOUNTAIN VIEW, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pro...

1 year ago - GlobeNewsWire

Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023

The Company also announced plans to present at Stifel Healthcare Conference The Company also announced plans to present at Stifel Healthcare Conference

1 year ago - GlobeNewsWire

Iridex Reimbursement Chaos Presents Buying Opportunity

IRIDEX Corporation's shares rallied over the past several weeks on news it was conducting a strategic review. On November 1, the stock cratered as the company disclosed possible concerns with Medicare...

1 year ago - Seeking Alpha